Suppr超能文献

肠脑互动障碍与回避/限制型食物摄入障碍的交集。

The Intersection of Disorders of Gut-Brain Interaction With Avoidant/Restrictive Food Intake Disorder.

机构信息

Division of Gastroenterology.

Department of Psychology, Florida State University, Tallahassee, FL.

出版信息

J Clin Gastroenterol. 2023 Aug 1;57(7):651-662. doi: 10.1097/MCG.0000000000001853.

Abstract

High rates of overlap exist between disorders of gut-brain interaction (DGBI) and eating disorders, for which common interventions conceptually conflict. There is particularly increasing recognition of eating disorders not centered on shape/weight concerns, specifically avoidant/restrictive food intake disorder (ARFID) in gastroenterology treatment settings. The significant comorbidity between DGBI and ARFID highlights its importance, with 13% to 40% of DGBI patients meeting full criteria for or having clinically significant symptoms of ARFID. Notably, exclusion diets may put some patients at risk for developing ARFID and continued food avoidance may perpetuate preexisting ARFID symptoms. In this review, we introduce the provider and researcher to ARFID and describe the possible risk and maintenance pathways between ARFID and DGBI. As DGBI treatment recommendations may put some patients at risk for developing ARFID, we offer recommendations for practical treatment management including evidence-based diet treatments, treatment risk counseling, and routine diet monitoring. When implemented thoughtfully, DGBI and ARFID treatments can be complementary rather than conflicting.

摘要

肠-脑相互作用障碍(DGBI)和饮食失调之间存在很高的重叠率,这两种疾病的共同干预措施在概念上存在冲突。在胃肠病学治疗环境中,人们越来越认识到不以体型/体重为中心的饮食失调,特别是回避/限制型食物摄入障碍(ARFID)。DGBI 和 ARFID 之间存在显著的共病性,表明其重要性,13%至 40%的 DGBI 患者符合 ARFID 的全部标准或具有明显的临床症状。值得注意的是,排除饮食可能使一些患者面临发展为 ARFID 的风险,而持续的食物回避可能会使先前存在的 ARFID 症状持续存在。在这篇综述中,我们向提供者和研究人员介绍了 ARFID,并描述了 ARFID 和 DGBI 之间可能存在的风险和维持途径。由于 DGBI 治疗建议可能使一些患者面临发展为 ARFID 的风险,我们提出了一些实用的治疗管理建议,包括基于证据的饮食治疗、治疗风险咨询和常规饮食监测。如果深思熟虑地实施,DGBI 和 ARFID 的治疗可以相辅相成,而不是相互冲突。

相似文献

1
The Intersection of Disorders of Gut-Brain Interaction With Avoidant/Restrictive Food Intake Disorder.
J Clin Gastroenterol. 2023 Aug 1;57(7):651-662. doi: 10.1097/MCG.0000000000001853.
3
Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms in Adolescent Patients With Disorders of Gut-Brain Interaction.
Int J Eat Disord. 2025 May;58(5):977-985. doi: 10.1002/eat.24386. Epub 2025 Feb 6.
6
Eating disorder symptoms, including avoidant/restrictive food intake disorder, in patients with disorders of gut-brain interaction.
Neurogastroenterol Motil. 2022 Aug;34(8):e14258. doi: 10.1111/nmo.14258. Epub 2021 Oct 24.
8
Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Adult Neurogastroenterology Patients.
Clin Gastroenterol Hepatol. 2020 Aug;18(9):1995-2002.e1. doi: 10.1016/j.cgh.2019.10.030. Epub 2019 Oct 24.

引用本文的文献

2
Mental and Somatic Conditions in Children With the Broad Avoidant Restrictive Food Intake Disorder Phenotype.
JAMA Pediatr. 2025 Apr 1;179(4):428-437. doi: 10.1001/jamapediatrics.2024.6065.
3
A Role for the Microbiota-Gut-Brain Axis in Avoidant/Restrictive Food Intake Disorder: A New Conceptual Model.
Int J Eat Disord. 2024 Dec;57(12):2321-2328. doi: 10.1002/eat.24326. Epub 2024 Nov 14.
4
Avoidant/Restrictive Food Intake Disorder: Review and Recent Advances.
Focus (Am Psychiatr Publ). 2024 Jul;22(3):288-300. doi: 10.1176/appi.focus.20240008. Epub 2024 Jun 28.
5
Eating Disorders: Updates and Innovations.
Focus (Am Psychiatr Publ). 2024 Jul;22(3):369-371. doi: 10.1176/appi.focus.24022009. Epub 2024 Jun 28.
6
Lactose malabsorption and intolerance in older adults.
Curr Opin Clin Nutr Metab Care. 2024 Jul 1;27(4):333-337. doi: 10.1097/MCO.0000000000001045. Epub 2024 Jun 6.
8
Avoidant/restrictive food intake disorder prevalence is high in children with gastroparesis and functional dyspepsia.
Neurogastroenterol Motil. 2024 May;36(5):e14777. doi: 10.1111/nmo.14777. Epub 2024 Mar 7.
9
Latent profile analysis reveals the central role of psychological symptoms in driving disease severity in chronic constipation.
Neurogastroenterol Motil. 2024 May;36(5):e14773. doi: 10.1111/nmo.14773. Epub 2024 Feb 23.

本文引用的文献

1
Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition.
JPEN J Parenter Enteral Nutr. 2023 May;47(4):541-549. doi: 10.1002/jpen.2493. Epub 2023 Mar 22.
4
Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome.
Aliment Pharmacol Ther. 2022 Aug;56(4):592-605. doi: 10.1111/apt.17111. Epub 2022 Jul 1.
5
Psychological Considerations in the Dietary Management of Patients With DGBI.
Am J Gastroenterol. 2022 Jun 1;117(6):985-994. doi: 10.14309/ajg.0000000000001766. Epub 2022 Apr 8.
6
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
Gastroenterology. 2022 May;162(6):1737-1745.e5. doi: 10.1053/j.gastro.2021.12.248. Epub 2022 Mar 23.
8
Caring for Adults With Eating Disorders in Primary Care.
Prim Care Companion CNS Disord. 2022 Jan 6;24(1):20nr02887. doi: 10.4088/PCC.20nr02887.
9
Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia.
Int J Mol Sci. 2021 Dec 19;22(24):13609. doi: 10.3390/ijms222413609.
10
Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Pediatric Neurogastroenterology Patients.
J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):588-592. doi: 10.1097/MPG.0000000000003369. Epub 2021 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验